Effect of sperm treatment with lysolecithin on in vitro outcomes of equine intracytoplasmic sperm injection.
Authors: Aguila L, Cabrera P, Arias M E, Silva M, Felmer R
Journal: Journal of equine veterinary science
Summary
# Editorial Summary: Lysolecithin Treatment in Equine ICSI Intracytoplasmic sperm injection has become established in equine reproduction for both clinical and commercial applications, yet optimisation opportunities remain—particularly regarding sperm membrane conditioning prior to injection. Aguila and colleagues investigated whether pre-treating stallion sperm with lysolecithin, a phospholipid that destabilises plasma and acrosomal membranes, might enhance embryonic development following ICSI in equine oocytes, using flow cytometry to assess membrane and DNA integrity alongside functional assays with both bovine and equine oocytes. At 0.08% concentration, lysolecithin successfully destabilised sperm membranes and induced acceptable levels of DNA damage (8–30%), yet the treated sperm demonstrated significantly reduced oocyte activation capacity in heterologous systems, necessitating chemical activation to achieve comparable cleavage rates to untreated controls. Rather than improving ICSI efficiency, the authors concluded that lysolecithin pre-treatment offers no developmental advantage and is therefore unnecessary in equine embryo production, providing valuable negative evidence that refines current understanding of sperm conditioning protocols. For practitioners utilising ICSI, these findings suggest that conventional protocols without lysolecithin treatment remain optimal, and that resources may be better directed towards other variables affecting embryo quality such as oocyte source, culture conditions, or activation timing.
Read the full abstract on PubMed
Practical Takeaways
- •Lysolecithin pre-treatment of sperm does not enhance equine ICSI outcomes and adds unnecessary steps to clinical protocols—standard ICSI procedures without lysolecithin treatment are sufficient
- •If lysolecithin-treated sperm must be used clinically, chemical oocyte activation should be employed to compensate for reduced activation ability
- •Current equine ICSI protocols are already optimized; efforts to improve efficiency should focus on other variables rather than sperm membrane destabilization
Key Findings
- •Lysolecithin at 0.08% concentration destabilized equine sperm plasma and acrosomal membranes while affecting DNA integrity within species-normal range (8-30%)
- •Lysolecithin-treated sperm showed reduced oocyte activation ability in heterologous ICSI assays
- •Chemical oocyte activation was required after equine ICSI with lysolecithin-treated sperm to achieve developmental rates similar to control groups
- •Lysolecithin pre-treatment did not improve efficiency of conventional or piezo-assisted equine ICSI and is not recommended